Response-based Treatment of High-risk Neuroblastoma
Clinical trial NCT02771743 · UNKNOWN
Trial details
- NCT number
- NCT02771743
- Sponsor
- Samsung Medical Center
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-01
- Primary completion
- 2020-03-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.